- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
New Radiation Shielding Superior to Lead for CT Scans
New custom-designed patient shielding devices should supplant traditional lead aprons for chest CT scans - and possibly every scan, regardless of body part. That’s according to the authors of a new study published in the British Journal of Radiology.
New custom-designed patient shielding devices should supplant traditional lead aprons for chest CT scans - and possibly every scan, regardless of body part. That’s according to the authors of a new study published in the British Journal of Radiology.
Medical physicist Gareth Iball, MSc, and colleagues at the Leeds General Infirmary used dosimeters to measure radiation levels throughout the abdomen and pelvis during chest CT scans of a RANDO phantom. Dose measurements were made with no shielding, with lead aprons and with the new shield around the abdomen and pelvis to quantify the achievable organ and effective dose reductions.
With the new out-of-plane shielding devices in place, Ball and colleagues measured “significant dose savings” throughout the abdomen and pelvis. All told, the new shielding provided effective dose saving of 4 percent over that obtained through conventional lead aprons.
“This could yield significant population dose savings and reductions in collective radiation risk,” the authors wrote.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
